Estate Planning Wills Trusts Estate and Gift Taxation Disability Planning Guardianships Conservatorships Trust Administration Probate Elder Law Wills & Living Wills Taxation Law Trusts Trust and Estate Law Probate Estate Administration
North Texas Orthopedics Sports 403 N Highland Ave, Sherman, TX 75092 903 892-3696 (phone), 903 893-9514 (fax)
Education:
Medical School Saint Louis University School of Medicine Graduated: 1979
Procedures:
Arthrocentesis Carpal Tunnel Decompression Hip Replacement Hip/Femur Fractures and Dislocations Knee Arthroscopy Knee Replacement Lower Arm/Elbow/Wrist Fractures and Dislocations Occupational Therapy Evaluation Shoulder Surgery Joint Arthroscopy Lower Leg/Ankle Fractures and Dislocations Shoulder Arthroscopy
Conditions:
Fractures, Dislocations, Derangement, and Sprains Internal Derangement of Knee Cartilage Intervertebral Disc Degeneration Lateral Epicondylitis Osteoarthritis
Languages:
English Spanish
Description:
Dr. Osterman graduated from the Saint Louis University School of Medicine in 1979. He works in Sherman, TX and specializes in Orthopaedic Surgery and Orthopedic Sports Medicine. Dr. Osterman is affiliated with Heritage Park Surgical Hospital, Texoma Medical Center and Wilson N Jones Regional Medical Center.
James A. Landro - Cheshire CT, US David G. Osterman - Glastonbury CT, US Walter Pickett - Madison CT, US
Assignee:
Bayer Pharmaceuticals Corporation - West Haven CT
International Classification:
C12Q 1/00
US Classification:
435 4
Abstract:
The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
James Landro - Cheshire CT, US David Osterman - Glastonbury CT, US Walter Pickett - Madison CT, US
Assignee:
Bayer Pharmaceuticals Corporation - West Haven CT
International Classification:
C12Q 1/48
US Classification:
435015000
Abstract:
The present invention relates to methods for assessing enzyme activity utilizing a phase partition system. In addition, the present invention also relates to methods for screening and identifying compounds that may be used, for example, for the treatment of diabetes, diabetes-related disorders, obesity, cardiovascular disease, cancer, and other diseases or disorders, using this phase partition system.
Kenneth F. Blount - Guilford CT, US Christen Douglas Forbes - North Haven CT, US David Osterman - Glastonbury CT, US
International Classification:
C12Q 1/68
US Classification:
435 612, 435 613
Abstract:
Methods, compositions and assays that measure the effect of a test compound on induction of ligand-induced ribowitch-mediated transcription termination are disclosed. The methods and the assays are useful in identifying drug candidates that modulate transcription by binding to a riboswitch, for example.
Philip D.G. Coish - North Haven CT, US Phil Wickens - Richmond Hill, CA Brian R. Dixon - Woodbridge CT, US David Osterman - Glastonbury CT, US Uday R. Khire - Orange CT, US Manuel Navia - Boston MA, US Judd Berman - Toronto, CA Harpreet Kaur - Brampton, CA Jeffrey Wilson - Toronto, CA Dennis Underwood - Jamaica Plain MA, US
The present invention relates novel diaminopteridine derivatives, their compositions and method of treatment comprising the same for use as anti-infectives.
Kenneth F. Blount - Guilford CT, US Philip D.G. Coish - North Haven CT, US Brian R. Dixon - Woodbridge CT, US David Osterman - Glastonbury CT, US Phil Wickens - Richmond Hill, CA Stephanie Avola - Woodbridge, CA Nick Baboulas - Scarborough, CA Angelica Bello - North York, CA Judd Berman - Toronto, CA Harpreet Kaur - Brampton, CA David Moon - Brampton, CA Vinh Pham - Markham, CA Andrew Roughton - Port Hope, CA Jeffrey Wilson - Toronto, CA Jeffrey A. Leiby - Kalamazoo MI, US Dennis Underwood - Jamica Plain MA, US Paul Adrian Aristoff - Dexter MI, US Heinrich J. Schostarez - Portage MI, US Robert A. Chrusciel - Portage MI, US Thomas R. Belliotti - Portage MI, US Bruce R. Evans - Kalamazoo MI, US Frank C. Sciavolino - Waterford CT, US Manuel A. Navia - Boston MA, US
The present invention relates novel flavin derivatives and other flavin derivatives, their use and compositions for use as riboswitch ligands and/or anti-infectives. The invention also provides method of making novel flavin derivatives.
Philip D. G. Coish - North Haven CT, US Brian R. Dixon - Woodbridge CT, US David Osterman - Glastonbury CT, US Paul Adrian Aristoff - Dexter MI, US Manuel Navia - Boston MA, US Frank Sciavolino - Waterford CT, US Stephanie Avola - Woodbridge, CA Nick Baboulas - Scarborough, CA Thomas R. Belliotti - Portage MI, US Angelica Bello - North york, CA Judd Berman - Toronto, CA Robert A. Chrusciel - Portage MI, US Bruce R. Evans - Holland MI, US Harpreet Kaur - Brampton, CA David Moon - Brampton, CA Vinh Pham - Markham, CA Andrew Roughton - Port Hope, CA Phil Wickens - Richmond Hill, CA Jeffrey Wilson - Toronto, CA Heinrich J. Schostarez - Portage MI, US
Richard D. Connell - New Haven CT David G. Osterman - Glastonbury CT Michael E. Katz - Wallingford CT
Assignee:
Miles Inc. - West Haven CT
International Classification:
C07K 5078 A61K 3805
US Classification:
514 19
Abstract:
A class of compounds that suppress human T-lymphocyte proliferation is disclosed. The active compounds essentially contain at least the following structure: ##STR1##.
Sulfonamide Aminomethylene Derivatives As Immunosuppressants
Richard D. Connell - New Haven CT David G. Osterman - Glastonbury CT Michael E. Katz - Wallingford CT Robert D. Dally - Branford CT
Assignee:
Miles Inc. - West Haven CT
International Classification:
A61K 340 C07D20700 C07D40502
US Classification:
514428
Abstract:
Compounds which suppress human T-lymphocyte proliferation are disclosed. The active compounds essentially contain at least the following structure: ##STR1##.